Home > News > Nanoscience Technologies Rated 'Speculative Buy/4'
December 13th, 2005
Nanoscience Technologies Rated 'Speculative Buy/4'
Nanoscience Technologies Inc. (OTCBB: NANS) has been rated "Speculative Buy/4" by Investrend Research analyst Oren Meytes, CFA, MSc, in an initiating Wall Street Research report.
Nanoscience Technologies, Inc.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014